SlideShare a Scribd company logo
Sidi A, Naik B, Muehlschlegel JD, Kirby DS, Lobato EB.
Ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs.
Br J Anaesth.2008 Apr;100(4):568-9. No abstract available.
PMID: 18344581 [PubMed - indexed for MEDLINE]
Sidi A, Naik B, Urdaneta F, Muehlschlegel JD, Kirby DS, Lobato EB
Treatment of ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs, by sildenafil
analogue (UK343-664) or nitroglycerin. Ann Card Anaesth.2008 Jul-Dec;11(2):97-104.
PMID: 18603749
Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB.
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and
myocardial stunning in pigs. Acta AnaesthesiolScand.2008 Mar;52(3):397-405.
PMID: 18269389 [PubMed - indexed for MEDLINE]
Sidi A, Muehlschlegel JD, Kirby DS, Kirby RR, Lobato EB
Treating ischemic left ventricular dysfunction with hypertonic saline administered after coronary occlusion in pigs. J
Cardiothorac Vasc Anesth.2007 Jun;21(3):400-5. Epub 2007 Apr 5.
PMID: 17544894 [PubMed - indexed for MEDLINE]
Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB
Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone,
administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs. Ann Card
Anaesth.2007 Jan;10(1):34-41. Erratum in: Ann Card Anaesth.2008 Jan-Jun;11(1):69. Muehschlegel,Jochen D
[corrected to Muehlschlegel, Jochen D].
PMID: 17455406 [PubMed - indexed for MEDLINE
Muehlschlegal JD, Lobato EB, Kirby DS, Arnaoutakis G, Sidi A.
Inhaled amyl nitrite effectively reverses acute catastrophic thromboxane-mediated pulmonary hypertension in pigs.
Annalsof Cardiac Anaesthesia 2007 July; 10(2): 113-120
Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB. Treatment of ischaemic left ventricular dysfunction with
milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
British Journal of Anaesthesia 2006; 97: 799-807
Lobato EB, Beaver T, Muelschlegel J, Kirby DS, Klodell C, Sidi A.
Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination
during thromboxane-induced acute pulmonary hypertension. British Journal of Anaesthesia 2006 March; 96(3):
317-22
Botero M, Kirby D, Lobato EB, Staples ED, Gravenstein N
Measurement of cardiac output before and after cardiopulmonary bypass:Comparison among aortic transit-time
ultrasound,thermodilution, and noninvasive partial CO2 rebreathing. J Cardiothorac Vasc Anesth.2004
Oct;18(5):563-72. PMID: 15578466 [PubMed - indexed for MEDLINE]
Bonnell MR, Urdaneta F, Kirby DS, Valdez NR, Beaver TM, Lobato EB
Effects of sildenafil analogue UK 343-664 on a porcine model of acute pulmonary hypertension.Ann Thorac Surg.
2004 Jan;77(1):238-42.
PMID: 14726068 [PubMed - indexed for MEDLINE]
Urdaneta F, Kirby D, Lobato EB.
“Effects of ascorbic acid vs ketorolac on myocardial ischemia-reperfusion during propofol anesthesia,” abstracted.
Anesthesia Analgesia 94:S34, 2002.
Urdaneta F, Kirby D, Lobato EB.
“Myocardial stunning following transient coronary occlusion in pigs: comparison of propofol vs isoflurane,”
abstracted. Anesthesia Analgesia 94:S36, 2002.
Lobato EB, Botero M, Kirby DS, Browd CR, Sidi A, Kirby RR.
“Effects of beta-blockade and PDEIII inhibition on myocardial ischemia and function during temporary coronary
occlusion,” abstracted. Anesthesia Analgesia 92:S28, 2001.
Lobato EB, Sulek CA, Hollis S, Kirby D, Kirby RR.
“Hypertonic saline improves stunned myocardium following transient coronary occlusion in pigs,” abstracted.
Anesthesia Analgesia 92:S29, 2001.
Lobato EB ,Botero M, Kirby DS, Browd CR, Sidi A.
“Effect of milrinone on myocardial ischemia and stunning in the presence of calcium channel blockade in pigs,”
abstracted.Anesthesia Analgesia 92:SCA104, 2001.
Lobato EB ,Botero M, Kirby DS, Browd CR, Sidi A.
“Effects of combined PDEIII and PDEV inhibition on a porcine model of acute pulmonary hypertension,”
abstracted. Anesthesia Analgesia 92:SCA125, 2001.
Botero M, Briesacher K, Kirby D, Gravenstein N, Hess P, Lobato EB.
“Comparison of noninvasive cardiac output using a partial CO2 rebreathing systemwith direct aortic flow
measurements during cardiac surgery,” abstracted. Anesthesia Analgesia 90:S31, 2000.
Botero M, Bresacher K, Kirby D, Gravenstein N, Hess P, Lobato EB.
“Comparison of noninvasive determination of cardiac output (CO) using a partial CO2 rebreathing
systemwith thermodilution during cardiac surgery,” abstracted. Anesthesia Analgesia 90:S32, 2000.
Botero M, Hess P, Kirby D, Briesacher K, Gravenstein N.
“Cardiac output measurement during off pump coronary artery bypass grafting (OPCABG): comparison of four
methods,” abstracted. Anesthesia Analgesia 90:SCA44, 2000.
Botero M, Hess P, Kirby D, Briesacher K, Gravenstein N.
“Measurement of cardiac output during coronary artery bypass grafting (CABG): comparison of pulmonary
artery catheter, noninvasive CO2 rebreathing, and direct aortic flow,” abstracted. Anesthesia Analgesia 90:SCA87,
2000.
Botero M, Khansarinia S, Kirby D, Gravenstein N, Lobato EB.
“Noninvasive cardiac output using partial CO2 rebreathing vs direct aortic flow measurements during
off pump coronary artery bypass grafting,” abstracted. Anesthesiology 93:A323, 2000.
Botero M, Khansarinia S, Kirby D, Gravenstein N, Lobato EB.
“Measurement of cardiac output in the intensive care unit after coronary artery bypass grafting (CABG):
comparison of pulmonary artery catheterand noninvasive partial CO2 rebreathing,” abstracted. Anesthesiology
93:A590, 2000.
Botero M, Gravenstein N, Briesacher KS, Kirby D, Hess P, Lobato EB. “Thermodilution cardiac output monitoring
vs direct measurement of aortic flow during coronary artery bypass grafting,” abstracted. Critical Care Medicine
27:193, 1999.

More Related Content

What's hot

L-Arginine May Benefit Individuals with Heart or Circulatory Condition
L-Arginine May Benefit Individuals with Heart or Circulatory ConditionL-Arginine May Benefit Individuals with Heart or Circulatory Condition
L-Arginine May Benefit Individuals with Heart or Circulatory Condition
Kenneth Brailsford
 
Atrial fibrillation and anticoagulants
Atrial fibrillation and anticoagulantsAtrial fibrillation and anticoagulants
Atrial fibrillation and anticoagulantsshahhcnt
 
Acei foundation of raas blocker in combination therapy by dr hendro
Acei foundation of raas blocker in combination therapy by dr hendroAcei foundation of raas blocker in combination therapy by dr hendro
Acei foundation of raas blocker in combination therapy by dr hendro
Suharti Wairagya
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy
cardiologycases
 
Mesurement of cretinine kinase from blood of a cardiac patient
Mesurement of cretinine kinase from blood of a cardiac patientMesurement of cretinine kinase from blood of a cardiac patient
Mesurement of cretinine kinase from blood of a cardiac patient
Atai Rabby
 
Question science 6
Question science 6Question science 6
Question science 6
Maylord Bonifaco
 
Septic cardiomyopathy colour
Septic cardiomyopathy   colourSeptic cardiomyopathy   colour
Septic cardiomyopathy colour
Palepu BN Gopal
 
Mycardial Dysfunction Sepsis
Mycardial Dysfunction SepsisMycardial Dysfunction Sepsis
Mycardial Dysfunction Sepsis
Soroy Lardo
 
Sepsis-Induced Cardiac Dysfunction
Sepsis-Induced Cardiac DysfunctionSepsis-Induced Cardiac Dysfunction
Sepsis-Induced Cardiac Dysfunctionshivabirdi
 
Myocardial dysfunction in sepsis jpcc jul aug 2018
Myocardial dysfunction in sepsis jpcc jul aug 2018Myocardial dysfunction in sepsis jpcc jul aug 2018
Myocardial dysfunction in sepsis jpcc jul aug 2018
Lokesh Tiwari
 
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure PatientsInterventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Duke Heart
 

What's hot (15)

ECG: Anterolateral MI with LBBB
ECG: Anterolateral MI with LBBBECG: Anterolateral MI with LBBB
ECG: Anterolateral MI with LBBB
 
L-Arginine May Benefit Individuals with Heart or Circulatory Condition
L-Arginine May Benefit Individuals with Heart or Circulatory ConditionL-Arginine May Benefit Individuals with Heart or Circulatory Condition
L-Arginine May Benefit Individuals with Heart or Circulatory Condition
 
Atrial fibrillation and anticoagulants
Atrial fibrillation and anticoagulantsAtrial fibrillation and anticoagulants
Atrial fibrillation and anticoagulants
 
Acei foundation of raas blocker in combination therapy by dr hendro
Acei foundation of raas blocker in combination therapy by dr hendroAcei foundation of raas blocker in combination therapy by dr hendro
Acei foundation of raas blocker in combination therapy by dr hendro
 
Hipokalemia
HipokalemiaHipokalemia
Hipokalemia
 
Hyvet Slide Set
Hyvet Slide SetHyvet Slide Set
Hyvet Slide Set
 
Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy
 
Mesurement of cretinine kinase from blood of a cardiac patient
Mesurement of cretinine kinase from blood of a cardiac patientMesurement of cretinine kinase from blood of a cardiac patient
Mesurement of cretinine kinase from blood of a cardiac patient
 
Question science 6
Question science 6Question science 6
Question science 6
 
Septic cardiomyopathy colour
Septic cardiomyopathy   colourSeptic cardiomyopathy   colour
Septic cardiomyopathy colour
 
Mycardial Dysfunction Sepsis
Mycardial Dysfunction SepsisMycardial Dysfunction Sepsis
Mycardial Dysfunction Sepsis
 
Sepsis-Induced Cardiac Dysfunction
Sepsis-Induced Cardiac DysfunctionSepsis-Induced Cardiac Dysfunction
Sepsis-Induced Cardiac Dysfunction
 
Myocardial dysfunction in sepsis jpcc jul aug 2018
Myocardial dysfunction in sepsis jpcc jul aug 2018Myocardial dysfunction in sepsis jpcc jul aug 2018
Myocardial dysfunction in sepsis jpcc jul aug 2018
 
Ref
RefRef
Ref
 
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure PatientsInterventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
 

Viewers also liked

Entrepreneurship an idea is an opportunity
Entrepreneurship  an idea is an opportunityEntrepreneurship  an idea is an opportunity
Entrepreneurship an idea is an opportunity
Karim Soliman
 
What is Cultural Entrepreneurship?
What is Cultural Entrepreneurship?What is Cultural Entrepreneurship?
What is Cultural Entrepreneurship?Creative Startups
 
Entrepreneurial Culture
Entrepreneurial CultureEntrepreneurial Culture
Entrepreneurial Culture
Naveen Minj
 
Chapter 1 the foundation of entrepreneurship (lecture 1 & 2)
Chapter 1 the foundation of entrepreneurship (lecture 1 & 2)Chapter 1 the foundation of entrepreneurship (lecture 1 & 2)
Chapter 1 the foundation of entrepreneurship (lecture 1 & 2)Afzaal Ali
 
Chapter 1 on Entrepreneurship
Chapter 1 on EntrepreneurshipChapter 1 on Entrepreneurship
Chapter 1 on EntrepreneurshipJaisiimman Sam
 
Introduction of entrepreneurship
Introduction of entrepreneurshipIntroduction of entrepreneurship
Introduction of entrepreneurshipRoslinaAhmad
 
"Past Present and Future of Entrepreneurship Education" presentation at USASB...
"Past Present and Future of Entrepreneurship Education" presentation at USASB..."Past Present and Future of Entrepreneurship Education" presentation at USASB...
"Past Present and Future of Entrepreneurship Education" presentation at USASB...
Massachusetts Institute of Technology
 
Entrepreneurship Lecture Notes Part 1
Entrepreneurship Lecture Notes Part 1Entrepreneurship Lecture Notes Part 1
Entrepreneurship Lecture Notes Part 1
Odofin Caleb
 
Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...
Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...
Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...
Jorge Saguinsin
 

Viewers also liked (9)

Entrepreneurship an idea is an opportunity
Entrepreneurship  an idea is an opportunityEntrepreneurship  an idea is an opportunity
Entrepreneurship an idea is an opportunity
 
What is Cultural Entrepreneurship?
What is Cultural Entrepreneurship?What is Cultural Entrepreneurship?
What is Cultural Entrepreneurship?
 
Entrepreneurial Culture
Entrepreneurial CultureEntrepreneurial Culture
Entrepreneurial Culture
 
Chapter 1 the foundation of entrepreneurship (lecture 1 & 2)
Chapter 1 the foundation of entrepreneurship (lecture 1 & 2)Chapter 1 the foundation of entrepreneurship (lecture 1 & 2)
Chapter 1 the foundation of entrepreneurship (lecture 1 & 2)
 
Chapter 1 on Entrepreneurship
Chapter 1 on EntrepreneurshipChapter 1 on Entrepreneurship
Chapter 1 on Entrepreneurship
 
Introduction of entrepreneurship
Introduction of entrepreneurshipIntroduction of entrepreneurship
Introduction of entrepreneurship
 
"Past Present and Future of Entrepreneurship Education" presentation at USASB...
"Past Present and Future of Entrepreneurship Education" presentation at USASB..."Past Present and Future of Entrepreneurship Education" presentation at USASB...
"Past Present and Future of Entrepreneurship Education" presentation at USASB...
 
Entrepreneurship Lecture Notes Part 1
Entrepreneurship Lecture Notes Part 1Entrepreneurship Lecture Notes Part 1
Entrepreneurship Lecture Notes Part 1
 
Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...
Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...
Entrepreneurship, introduction to entrepreneurship, definition of entrepreneu...
 

Similar to David Publications

Treatment of angina
Treatment of anginaTreatment of angina
Treatment of angina
Ramachandra Barik
 
Evidence-based management of CHF
Evidence-based management of CHFEvidence-based management of CHF
Evidence-based management of CHF
MedPeds Hospitalist
 
Visipaque Randomized IJC 2015
Visipaque Randomized IJC 2015Visipaque Randomized IJC 2015
Visipaque Randomized IJC 2015Edwin Chu
 
HF_Managing CHF with beta blcokers in the the era of ARNI.pptx
HF_Managing CHF with beta blcokers in the the era of ARNI.pptxHF_Managing CHF with beta blcokers in the the era of ARNI.pptx
HF_Managing CHF with beta blcokers in the the era of ARNI.pptx
JEEWANKUMAR14
 
Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial
Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial
Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial
Ricardo Mora MD
 
Holistik papdi by prof dr.jose rosma
Holistik papdi by prof dr.jose rosmaHolistik papdi by prof dr.jose rosma
Holistik papdi by prof dr.jose rosma
Suharti Wairagya
 
Guidelines Sepsis(Power Point)
Guidelines Sepsis(Power Point)Guidelines Sepsis(Power Point)
Guidelines Sepsis(Power Point)gatotaji
 
ICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathyICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathy
PRAVEEN GUPTA
 
cv latest dec 2014 linked in version
cv latest dec 2014 linked in versioncv latest dec 2014 linked in version
cv latest dec 2014 linked in versionJohn Hill
 
252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification
SHAPE Society
 
The Canary in the Coal Mine.
The Canary in the Coal Mine.The Canary in the Coal Mine.
The Canary in the Coal Mine.
thefirmest
 
bisoprolol...not all BB same.pptx
bisoprolol...not all BB same.pptxbisoprolol...not all BB same.pptx
bisoprolol...not all BB same.pptx
dkapila2002
 
Beta blockers in hypertension
Beta blockers in hypertensionBeta blockers in hypertension
Beta blockers in hypertensionAnkit Jain
 
FINAL.. beta blockers in cardiovascular disease.pptx
FINAL.. beta blockers in cardiovascular disease.pptxFINAL.. beta blockers in cardiovascular disease.pptx
FINAL.. beta blockers in cardiovascular disease.pptx
dkapila2002
 
HTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptxHTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptx
JAFAR ALSAID
 
European Society of Hypertension 2013 Hypertension guidelines presentation in...
European Society of Hypertension 2013 Hypertension guidelines presentation in...European Society of Hypertension 2013 Hypertension guidelines presentation in...
European Society of Hypertension 2013 Hypertension guidelines presentation in...
JAFAR ALSAID
 
Choque Cardiogenico.pptx
Choque Cardiogenico.pptxChoque Cardiogenico.pptx
Choque Cardiogenico.pptx
Jazmín Alejandra Ag
 

Similar to David Publications (20)

Treatment of angina
Treatment of anginaTreatment of angina
Treatment of angina
 
Evidence-based management of CHF
Evidence-based management of CHFEvidence-based management of CHF
Evidence-based management of CHF
 
Visipaque Randomized IJC 2015
Visipaque Randomized IJC 2015Visipaque Randomized IJC 2015
Visipaque Randomized IJC 2015
 
HF_Managing CHF with beta blcokers in the the era of ARNI.pptx
HF_Managing CHF with beta blcokers in the the era of ARNI.pptxHF_Managing CHF with beta blcokers in the the era of ARNI.pptx
HF_Managing CHF with beta blcokers in the the era of ARNI.pptx
 
Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial
Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial
Tabaquismo factor de riesgo cardiovascular y disfuncion endotelial
 
Holistik papdi by prof dr.jose rosma
Holistik papdi by prof dr.jose rosmaHolistik papdi by prof dr.jose rosma
Holistik papdi by prof dr.jose rosma
 
Guidelines Sepsis(Power Point)
Guidelines Sepsis(Power Point)Guidelines Sepsis(Power Point)
Guidelines Sepsis(Power Point)
 
ICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathyICD in Non-ischemic cardiomyopathy
ICD in Non-ischemic cardiomyopathy
 
cv latest dec 2014 linked in version
cv latest dec 2014 linked in versioncv latest dec 2014 linked in version
cv latest dec 2014 linked in version
 
ARB + Statin
ARB + StatinARB + Statin
ARB + Statin
 
252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification
 
Esv2n36
Esv2n36Esv2n36
Esv2n36
 
252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification
 
The Canary in the Coal Mine.
The Canary in the Coal Mine.The Canary in the Coal Mine.
The Canary in the Coal Mine.
 
bisoprolol...not all BB same.pptx
bisoprolol...not all BB same.pptxbisoprolol...not all BB same.pptx
bisoprolol...not all BB same.pptx
 
Beta blockers in hypertension
Beta blockers in hypertensionBeta blockers in hypertension
Beta blockers in hypertension
 
FINAL.. beta blockers in cardiovascular disease.pptx
FINAL.. beta blockers in cardiovascular disease.pptxFINAL.. beta blockers in cardiovascular disease.pptx
FINAL.. beta blockers in cardiovascular disease.pptx
 
HTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptxHTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptx
 
European Society of Hypertension 2013 Hypertension guidelines presentation in...
European Society of Hypertension 2013 Hypertension guidelines presentation in...European Society of Hypertension 2013 Hypertension guidelines presentation in...
European Society of Hypertension 2013 Hypertension guidelines presentation in...
 
Choque Cardiogenico.pptx
Choque Cardiogenico.pptxChoque Cardiogenico.pptx
Choque Cardiogenico.pptx
 

David Publications

  • 1. Sidi A, Naik B, Muehlschlegel JD, Kirby DS, Lobato EB. Ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs. Br J Anaesth.2008 Apr;100(4):568-9. No abstract available. PMID: 18344581 [PubMed - indexed for MEDLINE] Sidi A, Naik B, Urdaneta F, Muehlschlegel JD, Kirby DS, Lobato EB Treatment of ethanol-induced acute pulmonary hypertension and right ventricular dysfunction in pigs, by sildenafil analogue (UK343-664) or nitroglycerin. Ann Card Anaesth.2008 Jul-Dec;11(2):97-104. PMID: 18603749 Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB. Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs. Acta AnaesthesiolScand.2008 Mar;52(3):397-405. PMID: 18269389 [PubMed - indexed for MEDLINE] Sidi A, Muehlschlegel JD, Kirby DS, Kirby RR, Lobato EB Treating ischemic left ventricular dysfunction with hypertonic saline administered after coronary occlusion in pigs. J Cardiothorac Vasc Anesth.2007 Jun;21(3):400-5. Epub 2007 Apr 5. PMID: 17544894 [PubMed - indexed for MEDLINE] Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs. Ann Card Anaesth.2007 Jan;10(1):34-41. Erratum in: Ann Card Anaesth.2008 Jan-Jun;11(1):69. Muehschlegel,Jochen D [corrected to Muehlschlegel, Jochen D]. PMID: 17455406 [PubMed - indexed for MEDLINE Muehlschlegal JD, Lobato EB, Kirby DS, Arnaoutakis G, Sidi A. Inhaled amyl nitrite effectively reverses acute catastrophic thromboxane-mediated pulmonary hypertension in pigs. Annalsof Cardiac Anaesthesia 2007 July; 10(2): 113-120 Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. British Journal of Anaesthesia 2006; 97: 799-807 Lobato EB, Beaver T, Muelschlegel J, Kirby DS, Klodell C, Sidi A. Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension. British Journal of Anaesthesia 2006 March; 96(3): 317-22 Botero M, Kirby D, Lobato EB, Staples ED, Gravenstein N Measurement of cardiac output before and after cardiopulmonary bypass:Comparison among aortic transit-time ultrasound,thermodilution, and noninvasive partial CO2 rebreathing. J Cardiothorac Vasc Anesth.2004 Oct;18(5):563-72. PMID: 15578466 [PubMed - indexed for MEDLINE] Bonnell MR, Urdaneta F, Kirby DS, Valdez NR, Beaver TM, Lobato EB Effects of sildenafil analogue UK 343-664 on a porcine model of acute pulmonary hypertension.Ann Thorac Surg. 2004 Jan;77(1):238-42. PMID: 14726068 [PubMed - indexed for MEDLINE] Urdaneta F, Kirby D, Lobato EB. “Effects of ascorbic acid vs ketorolac on myocardial ischemia-reperfusion during propofol anesthesia,” abstracted. Anesthesia Analgesia 94:S34, 2002. Urdaneta F, Kirby D, Lobato EB.
  • 2. “Myocardial stunning following transient coronary occlusion in pigs: comparison of propofol vs isoflurane,” abstracted. Anesthesia Analgesia 94:S36, 2002. Lobato EB, Botero M, Kirby DS, Browd CR, Sidi A, Kirby RR. “Effects of beta-blockade and PDEIII inhibition on myocardial ischemia and function during temporary coronary occlusion,” abstracted. Anesthesia Analgesia 92:S28, 2001. Lobato EB, Sulek CA, Hollis S, Kirby D, Kirby RR. “Hypertonic saline improves stunned myocardium following transient coronary occlusion in pigs,” abstracted. Anesthesia Analgesia 92:S29, 2001. Lobato EB ,Botero M, Kirby DS, Browd CR, Sidi A. “Effect of milrinone on myocardial ischemia and stunning in the presence of calcium channel blockade in pigs,” abstracted.Anesthesia Analgesia 92:SCA104, 2001. Lobato EB ,Botero M, Kirby DS, Browd CR, Sidi A. “Effects of combined PDEIII and PDEV inhibition on a porcine model of acute pulmonary hypertension,” abstracted. Anesthesia Analgesia 92:SCA125, 2001. Botero M, Briesacher K, Kirby D, Gravenstein N, Hess P, Lobato EB. “Comparison of noninvasive cardiac output using a partial CO2 rebreathing systemwith direct aortic flow measurements during cardiac surgery,” abstracted. Anesthesia Analgesia 90:S31, 2000. Botero M, Bresacher K, Kirby D, Gravenstein N, Hess P, Lobato EB. “Comparison of noninvasive determination of cardiac output (CO) using a partial CO2 rebreathing systemwith thermodilution during cardiac surgery,” abstracted. Anesthesia Analgesia 90:S32, 2000. Botero M, Hess P, Kirby D, Briesacher K, Gravenstein N. “Cardiac output measurement during off pump coronary artery bypass grafting (OPCABG): comparison of four methods,” abstracted. Anesthesia Analgesia 90:SCA44, 2000. Botero M, Hess P, Kirby D, Briesacher K, Gravenstein N. “Measurement of cardiac output during coronary artery bypass grafting (CABG): comparison of pulmonary artery catheter, noninvasive CO2 rebreathing, and direct aortic flow,” abstracted. Anesthesia Analgesia 90:SCA87, 2000. Botero M, Khansarinia S, Kirby D, Gravenstein N, Lobato EB. “Noninvasive cardiac output using partial CO2 rebreathing vs direct aortic flow measurements during off pump coronary artery bypass grafting,” abstracted. Anesthesiology 93:A323, 2000. Botero M, Khansarinia S, Kirby D, Gravenstein N, Lobato EB. “Measurement of cardiac output in the intensive care unit after coronary artery bypass grafting (CABG): comparison of pulmonary artery catheterand noninvasive partial CO2 rebreathing,” abstracted. Anesthesiology 93:A590, 2000. Botero M, Gravenstein N, Briesacher KS, Kirby D, Hess P, Lobato EB. “Thermodilution cardiac output monitoring vs direct measurement of aortic flow during coronary artery bypass grafting,” abstracted. Critical Care Medicine 27:193, 1999.